CDC Moves Forward With Controversial Guinea-Bissau Vaccine Trial
The CDC has set aside $1.6 million to help fund a controversial hepatitis B vaccine trial in Guinea-Bissau, sparking widespread ethics concerns.
CDC Moves Forward With Controversial Guinea-Bissau Vaccine Trial Read More